Form 4: Pfizer Executive Rady A. Johnson Reports Stock Transactions

Executive Vice President Rady A. Johnson reports the earn-out of stock appreciation rights and related transactions involving Pfizer Inc. common stock.

Summary

• On February 23, 2024, Rady A. Johnson, an Executive Vice President at Pfizer Inc., reported transactions involving the company's common stock.
• These transactions included the earn-out of 29,436 stock appreciation rights at a price of $27.34.
• Shares were withheld to satisfy tax obligations (2,132 shares at $27.76) and to cover the exercise price of the stock appreciation rights (23,788 shares at $27.37).
• Following these transactions, Johnson directly owns 97,153 shares of Pfizer common stock and indirectly owns 6,301 shares through a Rule 16b-3 plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies like Pfizer. It provides transparency into the trading activities of insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership of shares.
• The transactions are part of the executive's compensation and therefore affect their personal financial situation.

Key Dates